Detalhe da pesquisa
1.
Anti-EGFR-Based Therapy in Recurrent or Metastatic HNSCC - What Difference Does it Make?
Cancer Invest
; 41(1): 93-100, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36239419
2.
Improving survival in metastatic renal cell carcinoma (mRCC) patients: do elderly patients benefit from expanded targeted therapeutic options?
World J Urol
; 40(10): 2489-2497, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-35916904
3.
Impact of sarcopenia in advanced and metastatic soft tissue sarcoma.
Int J Clin Oncol
; 26(11): 2151-2160, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-34318390
4.
Renal cell carcinoma in kidney transplant recipients: descriptive analysis and overview of a major German transplant center.
Future Oncol
; 15(32): 3739-3750, 2019 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-31664864
5.
FLA-IDA salvage chemotherapy combined with a seven-day course of venetoclax (FLAVIDA) in patients with relapsed/refractory acute leukaemia.
Br J Haematol
; 188(3): e11-e15, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31681986
6.
Age--an independent prognostic factor of clinical outcome in renal malignancies: results of a large study over two decades.
World J Urol
; 32(1): 115-21, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-24085371
7.
A Podcast Discussion on the Current Treatment Landscape for Renal Cell Carcinoma.
Adv Ther
; 40(9): 3610-3619, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37434067
8.
First Line Medical Treatment of Metastatic Renal Cell Carcinoma: A Podcast on Choosing Wisely and Managing Safely.
Adv Ther
; 40(9): 3620-3625, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37438555
9.
Enfortumab vedotin as a salvage option as 5th line therapy for metastatic urothelial bladder cancer.
Aktuelle Urol
; 2023 Nov 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-37963579
10.
Validation of CRP as prognostic marker for renal cell carcinoma in a large series of patients.
BMC Cancer
; 12: 399, 2012 Sep 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-22958305
11.
GATA5 CpG island methylation in renal cell cancer: a potential biomarker for metastasis and disease progression.
BJU Int
; 110(2 Pt 2): E144-52, 2012 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-22289415
12.
Does obesity influence the prognosis of metastatic renal cell carcinoma in patients treated with vascular endothelial growth factor-targeted therapy?
Oncologist
; 16(11): 1565-71, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-22020210
13.
Oxaliplatin pharmacokinetics on hemodialysis in a patient with diffuse large B cell lymphoma.
Ann Hematol
; 95(4): 649-50, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26846320
14.
Caveolin 1 protein expression in renal cell carcinoma predicts survival.
BMC Urol
; 11: 25, 2011 Dec 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-22152020
15.
Hepatic toxicity during regorafenib treatment in patients with metastatic gastrointestinal stromal tumors.
Mol Clin Oncol
; 13(6): 72, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-33005406
16.
Sarcoid-Like Lesions Mimicking Pulmonary Metastasis: A Case Series and Review of the Literature.
Oncol Res Treat
; 42(7-8): 382-386, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31137029
17.
Predictive Factors for Second-Line Therapy in Metastatic Renal Cell Carcinoma: A Retrospective Analysis.
J Kidney Cancer VHL
; 4(1): 8-15, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28405544
18.
Do programmed death 1 (PD-1) and its ligand (PD-L1) play a role in patients with non-clear cell renal cell carcinoma?
Med Oncol
; 33(6): 59, 2016 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-27165272
19.
Serum C-reactive protein: a prognostic factor in metastatic urothelial cancer of the bladder.
Med Oncol
; 30(4): 705, 2013 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-24005810
20.
Caveolin 1 mRNA is overexpressed in malignant renal tissue and might serve as a novel diagnostic marker for renal cancer.
Biomark Med
; 5(2): 219-25, 2011 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-21473727